Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    " October 13, 2013":" November 12, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Recruiting HIV-related Accelerated Aging of the Airway Epithelium
Conditions: HIV;   COPD;   Chronic Obstructive Pulmonary Disease;   Smoking
22 Not yet recruiting Comparing the Effectiveness of Two Alcohol+Adherence Interventions for HIV+ Youth
Condition: HIV
Intervention: Behavioral: Motivational Enhancement Therapy (MET)
23 Completed Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 Patients
Condition: HIV-1 Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
24 Completed Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women
Condition: Human Immunodeficiency Virus
Intervention: Drug: Dapivirine Vaginal Ring
25 Completed A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04
Condition: HIV
Interventions: Drug: 1% vaginally applied tenofovir gel;   Drug: Tenofovir film- 10mg;   Drug: Tenofovir Film-40 mg;   Other: HEC Placebo Gel;   Other: Placebo Vaginal Film
26 Active, not recruiting Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.
Condition: HIV
Intervention: Drug: emtricitabine / tenofovir 200/300 mg
27 Active, not recruiting Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection
Conditions: Tuberculosis;   HIV
Intervention: Drug: drug administration
28 Unknown  Modified Directly Observed Antiretroviral Therapy
Condition: HIV
Intervention: Other: Home visits
29 Completed Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL).
Conditions: HIV;   Depression
Interventions: Drug: raltegravir;   Drug: citalopram
30 Enrolling by invitation Botswana Combination Prevention Project
Condition: HIV
Interventions: Other: Combination Prevention;   Other: Enhanced Care
31 Active, not recruiting Adherence to HIV Therapy in Heroin Addicts: Oral vs. Extended Release Naltrexone
Condition: HIV+
Interventions: Drug: Oral naltrexone;   Drug: Naltrexone implant
32 Completed Analysis of Host Genetic Factors in the Occurrence of Anemia and on the Virological Response to a Peg-interferon/Ribavirin Therapy in HIV-HCV Co-infected Patients
Condition: HIV-HCV Co-infected Patients
Intervention: Genetic: blood samples
33 Completed
Has Results
A Trial of Radiofrequency Ablation for Anal Intraepithelial Neopplasia Using the HALO Ablation System
Condition: HIV-negative Subjects With Intra-anal Intraepithelial Neoplasia Containing High-grade Squamous Intraepithelial Lesions.
Intervention: Device: Radiofrequency Ablation (RFA) using the HALO Ablation System
34 Unknown  Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz
Condition: Drug Interaction
Intervention: Drug: Efavirenz
35 Completed Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis
Conditions: Latent Tuberculosis;   Latent Tuberculosis Bacteriology and Histology Unknown
Intervention: Biological: Aeras-456
36 Completed Multi-Level HIV Prevention for Pregnant Drug Abusers
Condition: Substance Related Disorders
Intervention: Behavioral: Enhanced Behavioral Skills Training

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years